Becton, Dickinson and Company

BDX Healthcare Medical Instruments & Supplies

In the quarter to June 2026, revenue grew 5.44%, EPS fell 31.5%, free cash flow fell 31.6% and total debt fell 22.9%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years, revenue growth for three.

191.75 2.01 −1.04%
Market cap
$52.8B
P/E
57.8×
Fwd P/E
37.7×
Dividend yield
2.07%
F-score
7/9
Altman Z
1.84
Beneish M
−2.64
Dividend safety
67/100

Becton, Dickinson and Company (BDX) Free cash flow

Alert me on Free cash flow

Becton, Dickinson and Company's free cash flow for fiscal 2025 was $2.7B, down 14.4% from $3.1B in fiscal 2024. Over the twelve months to 30 June 2026 it was $3.2B. Over the past ten years it has ranged from $1.1B (fiscal 2015) to $3.1B (fiscal 2024); the current reading is higher than 82% of that period. Becton, Dickinson and Company ranks 2nd of 54 Medical Instruments & Supplies companies by free cash flow.

Free cash flow, annual

Embed this chart

Annual newest first

Period Free cash flow Change
FY2025 $2.7B (14.40%)
FY2024 $3.1B 47.40%
FY2023 $2.1B 41.26%
FY2022 $1.5B (48.91%)
FY2021 $2.9B 35.24%
FY2020 $2.2B (8.64%)
FY2019 $2.4B 20.46%
FY2018 $2.0B 8.06%
FY2017 $1.8B (2.30%)
FY2016 $1.9B 64.55%

Quarterly newest first

Period Free cash flow Change
Jun 2026 $633.0M 15.93%
Mar 2026 $546.0M (0.55%)
Dec 2025 $549.0M (62.78%)
Sep 2025 $1.5B 59.46%
42 more quarters

Against its own ten years

Low $1.1B High $3.1B
Ten-year median $2.1B
Current reading's percentile 82

Free cash flow against peers

What Free cash flow is

Free Cash Flow tells an investor how much cash a company’s operations generate after paying for its investment in physical and intangible assets.

Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)

The full definition of Free cash flow →

More on BDX